Is Your Medical Practice Protected from Counterfeit?

Approved vendor FL Dept of HealthIf you manage a medical practice of any type, then you are aware of the Florida legislation that went into effect in 2011 requiring all licensed healthcare practitioners prescribing controlled substances to use counterfeit-proof prescription blanks. These prescription blanks must be obtained from vendors approved by the Florida Department of Health, and those vendors must provide the state with very specific monthly reporting to help the government keep track of legal and illegal prescriptions being filled. Your practice’s prescription pads deserve to be state approved and counterfeit-proof while also looking stylish, so it makes sense to buy them from a graphic design company with both the experience and credentials.

Why Counterfeit-Proof Prescription Blanks?

Unfortunately, we live in a country rife with drug abuse, and a great deal of that drug abuse stems from controlled substances that doctors have the ability to provide to patients as they see fit. Oxycontin, oxycodone, and other painkillers all have their legitimate purposes, but it has become an all-too-common practice for addicts to create counterfeit prescriptions. They bring those counterfeit prescriptions of whatever drug they are craving, and have it filled by a pharmacy. This is a problem for a number of reasons, including the growth of prescription drug abuse and the liability of the doctor’s offices which didn’t actually write such a prescription. The counterfeit-proof prescription blanks solve that problem by making them impossible to recreate.

Have They Worked?

Five years has passed since counterfeit-proof prescription blanks became mandatory, and local pharmacists have seen a significant drop in the number of people trying to provide fake prescriptions from real doctors. In addition to being blue or green, the tamper-proof forms also need to be printed on watermarked paper so that the words “void” or “illegal” appear when photocopied. State officials even assert that the 20 percent drop in oxycodone sales in 2012 was partly due to the new prescription pad laws.


Comments are closed.